Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone)

Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) is filed as Corticosteroid [EPC]. The sections below restate public label fields stored for this profile.

Class
Corticosteroid [EPC]
Generic name
neomycin sulfate, polymyxin b sulfate, and dexamethasone
Route
OPHTHALMIC
Dosage forms
HOW SUPPLIED Product: 50090-6181 NDC: 50090-6181-0 3.5 g in a TUBE / 1 in a CARTON
Generic available
Yes
Manufacturer
A-S Medication Solutions

Approved uses

For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Neisseria species , and Pseudomonas aeruginosa . This product does not provide adequate coverage against: Serratia marcescens and Streptococci, including Streptococcus pneumoniae .

How it works

Corticosteroids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticosteroids may inhibit the body's defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant in a particular case. When a decision to administer both a corticosteroid and an antimicrobial is made, the administration of such drugs in combination has the advantage of greater patient compliance and convenience, with the added assurance that the appropriate dosage of both drugs is administered, plus assured compatibility of ingredients when both types of drugs are in the same formulation and, particularly, that the correct volume of drug is delivered and retained. The relative potency of corticosteroids depends on the molecular structure, concentration and release from the vehicle.

Warnings and precautions

NOT FOR INJECTION. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Employment of steroid medication in the treatment of herpes simplex requires great caution; frequent slit lamp microscopy is recommended. Prolonged use may result in glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision, and posterior subcapsular cataract formation. Prolonged use may suppress the host response and thus increase the hazard of secondary ocular infections. In acute purulent conditions or parasitic infections of the eye, steroids may mask infection or enhance existing infection. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. If this product is used for 10 days or longer, intraocular pressure (IOP) should be routinely monitored even though it may be difficult in children and uncooperative patients. Steroids should be used with caution in the presence of glaucoma. IOP should be checked frequently. The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. Products containing neomycin sulfate may cause cutaneous sensitization. Sensitivity to topically administered aminoglycosides, such as neomycin, may occur in some patients. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticaria, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If hypersensitivity develops during use of the product, treatment should be discontinued. Cross-hypersensitivity to other aminoglycosides can occur, and the possibility that patients who become sensitized to topical neomycin may also be sensitive to other topical and/or systemic aminoglycosides should be considered.

Contraindications

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment is contraindicated in epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of ocular structures. Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment is also contraindicated in individuals with known or suspected hypersensitivity to a component of the medication. (Hypersensitivity to the antibiotic component occurs at a higher rate than for other components.)

Adverse reactions

Adverse reactions have occurred with steroid/anti-infective combination drugs which can be attributed to the steroid component, the anti-infective component, or the combination. Exact incidence figures are not available since no denominator of treated patients is available. Reactions occurring most often from the presence of the anti-infective ingredients are allergic sensitizations. The reactions due to the steroid component are: elevation of IOP with possible development of glaucoma, and infrequent optic nerve damage; posterior subcapsular cataract formation; and delayed wound healing. Secondary Infection: The development of secondary infection has occurred after use of combinations containing steroids and antimicrobials. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroid. The possibility of fungal invasion must be considered in any persistent corneal ulceration where steroid treatment has been used. Keratitis, conjunctivitis, corneal ulcers, and conjunctival hyperemia have occasionally been reported following use of steroids. Secondary bacterial ocular infection following suppression of host responses also occurs. Additional adverse reactions identified from post marketing use include ulcerative keratitis, headache, and Stevens-Johnson syndrome. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Dosage and administration

Apply a small amount into the conjunctival sac(s) up to three or four times daily. How to Apply Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment: Tilt your head back. Place a finger on your cheek just under your eye and gently pull down until a "V" pocket is formed between your eyeball and your lower lid. Place a small amount (about 1/2 inch) of Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment in the "V" pocket. Do not let the tip of the tube touch your eye. Look downward before closing your eye. Not more than 8 g should be prescribed initially and the prescription should not be refilled without further evaluation as outlined in PRECAUTIONS above.

Common questions

What is Neomycin and polymyxin b sulfates and dexamethasone approved to treat?

According to its FDA label, Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) is approved for: For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, an… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Neomycin and polymyxin b sulfates and dexamethasone?

Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) belongs to the Corticosteroid [EPC] class of medications.

What form does Neomycin and polymyxin b sulfates and dexamethasone come in?

The FDA label lists Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) as: HOW SUPPLIED Product: 50090-6181 NDC: 50090-6181-0 3.5 g in a TUBE / 1 in a CARTON; ophthalmic route. Available strengths and packaging vary by manufacturer.

Is there a generic version of Neomycin and polymyxin b sulfates and dexamethasone?

Yes. A generic version of Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) is available in the U.S. Ask your pharmacist about substitution.

Does Neomycin and polymyxin b sulfates and dexamethasone have a Boxed Warning?

Our ingest of the FDA label for Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

Is Neomycin and polymyxin b sulfates and dexamethasone currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was Neomycin and polymyxin b sulfates and dexamethasone approved by the FDA?

The FDA record lists the approval date for Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone) as 1994-07-25.

Who makes Neomycin and polymyxin b sulfates and dexamethasone?

The FDA label lists A-S Medication Solutions as a labeler/manufacturer of Neomycin and polymyxin b sulfates and dexamethasone (neomycin sulfate, polymyxin b sulfate, and dexamethasone). Multiple firms may market generics of the same molecule.

How should Neomycin and polymyxin b sulfates and dexamethasone be stored?

The FDA label states: "Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment is supplied as a STERILE ointment in a pre-printed aluminum tube with a natural HDPE cannula and a white HDPE cap. (3.5 g in an aluminum tube NDC 68…" Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…